Sean E Harper - Net Worth and Insider Trading

Sean E Harper Net Worth

The estimated net worth of Sean E Harper is at least $17 Million dollars as of 2024-05-12. Sean E Harper is the EVP, Research & Development of Amgen Inc and owns about 56,082 shares of Amgen Inc (AMGN) stock worth over $17 Million. Details can be seen in Sean E Harper's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Sean E Harper has not made any transactions after 2018-07-16 and currently still holds the listed stock(s).

Transaction Summary of Sean E Harper

To

Sean E Harper Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Sean E Harper owns 2 companies in total, including Amgen Inc (AMGN) , and Acelyrin Inc (SLRN) .

Click here to see the complete history of Sean E Harper’s form 4 insider trades.

Insider Ownership Summary of Sean E Harper

Ticker Comapny Transaction Date Type of Owner
AMGN Amgen Inc 2018-07-16 EVP & Research & Development
SLRN Acelyrin Inc 2023-05-04 10 percent owner

Sean E Harper Latest Holdings Summary

Sean E Harper currently owns a total of 1 stock. Sean E Harper owns 56,082 shares of Amgen Inc (AMGN) as of July 16, 2018, with a value of $17 Million.

Latest Holdings of Sean E Harper

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
AMGN Amgen Inc 2018-07-16 56,082 310.15 17,393,832

Holding Weightings of Sean E Harper


Sean E Harper Form 4 Trading Tracker

According to the SEC Form 4 filings, Sean E Harper has made a total of 0 transactions in Amgen Inc (AMGN) over the past 5 years. The most-recent trade in Amgen Inc is the sale of 1,525 shares on July 16, 2018, which brought Sean E Harper around $298,458.

Insider Trading History of Sean E Harper

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Sean E Harper Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Sean E Harper Ownership Network

Ownership Network List of Sean E Harper

No Data

Ownership Network Relation of Sean E Harper


Sean E Harper Owned Company Details

What does Amgen Inc do?

Who are the key executives at Amgen Inc?

Sean E Harper is the EVP & Research & Development of Amgen Inc. Other key executives at Amgen Inc include SVP & CCO Nancy A. Grygiel , SVP & Gen. Counsel & Secy. Jonathan P Graham , and VP & Finance & CAO Matthew C. Busch .

Amgen Inc (AMGN) Insider Trades Summary

Over the past 18 months, Sean E Harper made no insider transaction in Amgen Inc (AMGN). Other recent insider transactions involving Amgen Inc (AMGN) include a net sale of 4,213 shares made by Nancy A. Grygiel , a net sale of 10,000 shares made by Jonathan P Graham , and a net sale of 9,558 shares made by Murdo Gordon .

In summary, during the past 3 months, insiders sold 2,117 shares of Amgen Inc (AMGN) in total and bought 0 shares, with a net sale of 2,117 shares. During the past 18 months, 23,771 shares of Amgen Inc (AMGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 23,771 shares.

Amgen Inc (AMGN)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Amgen Inc Insider Transactions

No Available Data

Sean E Harper Mailing Address

Above is the net worth, insider trading, and ownership report for Sean E Harper. You might contact Sean E Harper via mailing address: Amgen Inc., One Amgen Center Drive, Thousand Oaks Ca 91320-1799.

Discussions on Sean E Harper

No discussions yet.